ADC Therapeutics (ADCT) Retained Earnings (2019 - 2023)
Historic Retained Earnings for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to -$339000.0.
- ADC Therapeutics' Retained Earnings rose 5973.87% to -$339000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was -$339000.0, marking a year-over-year increase of 5973.87%. This contributed to the annual value of -$1.1 billion for FY2022, which is 59858971748.63% down from last year.
- Latest data reveals that ADC Therapeutics reported Retained Earnings of -$339000.0 as of Q3 2023, which was up 5973.87% from -$46000.0 recorded in Q2 2023.
- In the past 5 years, ADC Therapeutics' Retained Earnings registered a high of $301000.0 during Q2 2021, and its lowest value of -$1.1 billion during Q4 2022.
- Over the past 5 years, ADC Therapeutics' median Retained Earnings value was -$277000.0 (recorded in 2023), while the average stood at -$128.4 million.
- As far as peak fluctuations go, ADC Therapeutics' Retained Earnings soared by 14865.81% in 2021, and later crashed by 96000.0% in 2023.
- Over the past 5 years, ADC Therapeutics' Retained Earnings (Quarter) stood at $69.0 in 2019, then tumbled by 926085.51% to -$638930.0 in 2020, then tumbled by 109437.84% to -$699.9 million in 2021, then tumbled by 56.52% to -$1.1 billion in 2022, then soared by 99.97% to -$339000.0 in 2023.
- Its Retained Earnings was -$339000.0 in Q3 2023, compared to -$46000.0 in Q2 2023 and -$215000.0 in Q1 2023.